• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2021 Aug 21;21(1):850.
doi: 10.1186/s12879-021-06574-x.
Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission


Toshifumi Ninomiya[SUP] #[/SUP][SUP] 1 2 [/SUP], Kohei Otsubo[SUP] #[/SUP][SUP] 3 [/SUP], Teppei Hoshino[SUP] 4 [/SUP], Mototsugu Shimokawa[SUP] 5 [/SUP], Megumi Nakazawa[SUP] 2 [/SUP], Yoriko Sato[SUP] 2 [/SUP], Hironori Mikumo[SUP] 2 [/SUP], Satoru Kawakami[SUP] 2 6 [/SUP], Shun Mizusaki[SUP] 1 2 [/SUP], Yusuke Mori[SUP] 4 [/SUP], Hidenobu Arimura[SUP] 1 [/SUP], Yuko Tsuchiya-Kawano[SUP] 1 [/SUP], Koji Inoue[SUP] 1 [/SUP], Yujiro Uchida[SUP] 2 [/SUP], Yoichi Nakanishi[SUP] 7 [/SUP]



Affiliations

Abstract

Background: Although the risk factors for coronavirus disease 2019 (COVID-19) mortality have been identified, there is limited information about the risk factors for disease progression after hospitalization among Japanese patients with COVID-19 exhibiting no or mild symptoms.
Methods: All 302 consecutive patients who were admitted to our institutions and diagnosed with COVID-19 between March and December 2020 were retrospectively assessed. Ultimately, 210 adult patients exhibiting no or mild symptoms on admission were included in the analysis. They were categorized into the stable (no oxygen needed) and worsened (oxygen needed) groups, and their characteristics and laboratory data were compared.
Results: Among 210 patients, 49 progressed to a severe disease stage, whereas 161 did not. The mean patient age was 52.14 years, and 126 (60.0%) patients were male. The mean body mass index (BMI) was 23.0 kg/m[SUP]2[/SUP], and 71 patients were overweight (BMI ≥ 25 kg/m[SUP]2[/SUP]). Multivariate logistic analysis showed that old age, overweight, diabetes mellitus (DM), and high serum ferritin levels were independent risk factors for disease progression.
Conclusions: Clinicians should closely observe patients with COVID-19, especially those with risk factors such as old age, overweight, DM, and high serum ferritin levels, regardless of whether they have no or mild symptoms.

Keywords: COVID-19; Disease progression; Risk factors.
 
Back
Top Bottom